A recent study revealed that in all four subtypes of breast cancer tissue, mRNA levels of HASPIN were significantly higher than in corresponding adjacent normal tissues, suggesting that HASPIN is a potential target for breast cancer therapy [12]. Here, HASPIN is linked to breast carcinoma.